Lyell Immunopharma

Lyell is an immuno-oncology company dedicated to reprogramming T cells to achieve curative therapies for solid tumors. The company takes a deliberate approach to solving what it believes to be the major barriers to successful adoptive T cell therapy: T cell exhaustion and loss of durable stemness, w... Read more


Series C




Org chart

Lynn Seely
President & CEO
Tina Albertson
Chief Medical Officer & Head of Development
Richard Goold
Chief Information Officer
Stephen Hill
Chief Operating Officer
Gary Lee
Chief Scientific Officer
Charles Newton
Chief Financial Officer
Lisa Ryan
Chief People Officer
Rahsaan W. Thompson
Chief Legal Officer
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.